RANI logo

RANI

Profile

Full Name

Rani Therapeutics Holdings, Inc.

Ticker Symbol

RANI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 30, 2021

Indexes

Not included

Website

http://www.ranitherapeutics.com

Employees

105

Key Details

Price

$1.25(+1.22%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.03M

Annual EPS

-$1.05(+21.05% YoY)

PE ratio

-

Next earnings date

May 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.25
RANI price is $1.25

30-Day Relative Volume

1.09
RANI 30-day relative volume is 1.09

Price Performance

Price Today change

+1.22%
RANI price is up +1.22% today

Price YTD change

-9.12%
RANI price is down -9.12% since January 1st

Price 1-year change

-78.39%
RANI price is down -78.39% year-on-year

Price 3-year change

-90.42%
RANI price is down -90.42% over the past 3 years

Price Range

Price All-time high

$36.27
RANI price is currently -96.57% below its historical high of $36.27

Price 3-year low

$1.03
RANI price is currently +20.87% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$41.72M
RANI market capitalization is $41.72 million

Market cap 3-year change

-86.84%
RANI market capitalization is down -86.84% over the past 3 years

Market cap All-time high

$689.92M
RANI market capitalization is currently -93.95% below its historical high of $689.92 million

Market cap sector rank

35.61%
RANI market capitalization is higher than 35.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+27.42%
RANI shares outstanding is up +27.42% year-on-year

Shares Outstanding 3-Year Change

+37.41%
RANI shares outstanding is up +37.41% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.76
RANI beta is 1.76

200-day SMA

$2.13
RANI price is currently -41.61% below its 200-day simple moving average

50-day SMA

$1.46
RANI price is currently -14.70% below its 50-day simple moving average

RSI

44.83
RANI 14-day relative strength index is 44.83

Volume

1.09
RANI 30-day relative volume is 1.09

ATR

$0.11
RANI average true range is $0.11

10-day Historical Volatility

154.32%
RANI 10-day historical volatility is 154.32%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.03M
RANI annual revenue is $1.03 million

Revenue Analysts estimate

$166.67K
RANI annual revenue is currently +516.79% higher than the consensus analysts' forecast

Revenue 1-year change

-
RANI annual revenue 1-year change is unknown

Revenue Sector rank

12.43%
RANI annual revenue is higher than 12.43% of companies in Healthcare sector

EPS

EPS

-$1.05
RANI annual earnings per share is -$1.05

EPS Analysts estimate

-$0.85
RANI annual earnings per share is currently +23.53% higher than the consensus analysts' forecast

EPS 1-year change

+21.05%
RANI annual earnings per share is up +21.05% year-on-year

EPS Sector rank

55.67%
RANI annual earnings per share is higher than 55.67% of companies in Healthcare sector

Profit

Gross profit

-
RANI annual gross profit value is unknown

Gross margin

-
RANI annual gross profit margin value is unknown

Operating profit

-$49.60M
RANI annual operating income is -$49.60 million

Operating margin

-4824.90%
RANI annual operating profit margin is -4824.90%

Net income

-$30.02M
RANI annual net profit is -$30.02 million

Net margin

-2920.04%
RANI annual net profit margin is -2920.04%

Expenses

Total expenses

$50.63M
RANI annual total expenses is $50.63 million

Operating expenses

$50.63M
RANI annual total operating expenses is $50.63 million

Cost of goods sold

-
RANI annual cost of goods sold value is unknown

Selling, general & administrative expenses

$23.95M
RANI annual SGA is $23.95 million

Depreciation and amortization

$1.03M
RANI annual depreciation & amortization is $1.03 million

Interest expense

$5.03M
RANI annual interest expense is $5.03 million

Income tax

-
RANI annual income tax value is unknown

EBIT & EBITDA

EBIT

-$51.55M
RANI annual earnings before interest & taxes is -$51.55 million

EBITDA

-$50.52M
RANI annual EBITDA is -$50.52 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$36.63M
RANI annual total assets is $36.63 million

Non current assets

$6.89M
RANI annual long term assets is $6.89 million

Current assets

$29.74M
RANI annual total current assets is $29.74 million

Cash and cash equivalents

$3.76M
RANI annual cash & cash equivalents is $3.76 million

Accounts receivable

-
RANI annual accounts receivable value is unknown

Inventory

-
RANI annual inventory value is unknown

Liabilities

Total liabilities

$33.14M
RANI annual total liabilities is $33.14 million

Long term liabilities

$13.25M
RANI annual total long term liabilities is $13.25 million

Current liabilities

$19.89M
RANI annual total current liabilities is $19.89 million

Accounts payable

$1.36M
RANI annual accounts payable is $1.36 million

Debt

Total debt

$29.71M
RANI annual total debt is $29.71 million

Total debt 1-year change

-1.3%
RANI annual total debt is down -1.3% year-on-year

Long term debt

$13.25M
RANI annual long term debt is $13.25 million

Short term debt

$16.46M
RANI annual short term debt is $16.46 million

Equity & Capital

Shareholders equity

$1.99M
RANI annual stockholders equity is $1.99 million

Book value

$1.99M
RANI annual book value is $1.99 million

Retained earnings

-$102.91M
RANI annual retained earnings is -$102.91 million

Working capital

$9.85M
RANI annual working capital is $9.85 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$35.50M
RANI annual cash flow from operations is -$35.50 million

Cash from operations 1-year change

+30.72%
RANI annual cash flow from operations is up +30.72% year-on-year

Cash from investing

$19.81M
RANI annual cash flow from investing activities is $19.81 million

Cash from investing 1-year change

-33.66%
RANI annual cash flow from investing activities is down -33.66% year-on-year

Cash from financing

$13.59M
RANI annual cash flow from financing activities is $13.59 million

Cash from financing 1-year change

+5730.47%
RANI annual cash flow from financing activities is up +5730.47% year-on-year

CAPEX

CAPEX

$268.00K
RANI annual capital expenditures is $268.00 thousand

CAPEX 1-year change

-78.19%
RANI annual capital expenditures is down -78.19% year-on-year

Free Cash Flow

Free cash flow

-$35.76M
RANI annual free cash flow is -$35.76 million

Free cash flow 1-year change

+31.83%
RANI annual free cash flow is up +31.83% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RANI annual gross profit margin value is unknown

Operating margin

-4824.90%
RANI annual operating profit margin is -4824.90%

Net margin

-2920.04%
RANI annual net profit margin is -2920.04%

ROA & ROE

ROA

-63.50%
RANI annual return on assets is -63.50%

ROE

-207.48%
RANI annual return on equity is -207.48%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RANI price to earnings ratio value is unknown

PE ratio Sector rank

-
RANI price to earnings ratio is unknown

PB Ratio

PB ratio

20.94
RANI price to book ratio is 20.94

PB ratio Sector rank

96.87%
RANI price to book ratio is higher than 96.87% of companies in Healthcare sector

PS Ratio

PS ratio

40.58
RANI price to sales ratio is 40.58

PS ratio Sector rank

91.03%
RANI price to sales ratio is higher than 91.03% of companies in Healthcare sector

Enterprise value

Enterprise value

$67.67M
RANI enterprise value is $67.67 million

Enterprise value Sector rank

45.04%
RANI enterprise value is higher than 45.04% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.34
RANI EV/EBITDA is -1.34

EV/EBITDA Sector rank

38.7%
RANI EV/EBITDA is higher than 38.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.50
RANI annual current ratio is 1.50

Quick ratio

-
RANI annual quick ratio value is unknown

Leverage

Debt to equity

12.36
RANI annual debt to equity ratio is 12.36

Interest coverage ratio

-10.24
RANI annual interest coverage ratio is -10.24

Risk & Stability

Piotroski F-Score

-
RANI piotroski f-score value is unknown

Altman Z-Score

-7.47
RANI altman z-score is -7.47

Analyst ratings

Recent major analysts updates

Apr 3, 25 HC Wainwright & Co.
Buy
Feb 26, 25 Canaccord Genuity
Buy
Feb 7, 25 HC Wainwright & Co.
Buy
Nov 19, 24 HC Wainwright & Co.
Buy
Oct 18, 24 HC Wainwright & Co.
Buy
Aug 16, 24 HC Wainwright & Co.
Buy
Aug 2, 24 Oppenheimer
Outperform
Jun 25, 24 HC Wainwright & Co.
Buy
Jun 14, 24 Maxim Group
Buy
Jun 13, 24 Rodman & Renshaw
Buy

Institutional Ownership

Similar stocks

MRSN logo
Mersana Therapeutics (MRSN)
ATNM logo
Actinium Pharmaceuticals (ATNM)
OPGN logo
OpGen (OPGN)
SKYE logo
Skye Bioscience (SKYE)
STTK logo
Shattuck Labs (STTK)
ARMP logo
Armata Pharmaceuticals (ARMP)
APYX logo
Apyx Medical (APYX)
AADI logo
Aadi Bioscience (AADI)
ECOR logo
electroCore (ECOR)
  • What is the ticker symbol for Rani Therapeutics Holdings?
  • Does Rani Therapeutics Holdings pay dividends?
  • What sector is Rani Therapeutics Holdings in?
  • What industry is Rani Therapeutics Holdings in?
  • What country is Rani Therapeutics Holdings based in?
  • When did Rani Therapeutics Holdings go public?
  • Is Rani Therapeutics Holdings in the S&P 500?
  • Is Rani Therapeutics Holdings in the NASDAQ 100?
  • Is Rani Therapeutics Holdings in the Dow Jones?
  • When was Rani Therapeutics Holdings's last earnings report?
  • When does Rani Therapeutics Holdings report earnings?
  • Should I buy Rani Therapeutics Holdings stock now?

What is the ticker symbol for Rani Therapeutics Holdings?

The ticker symbol for Rani Therapeutics Holdings is NASDAQ:RANI

Does Rani Therapeutics Holdings pay dividends?

No, Rani Therapeutics Holdings does not pay dividends

What sector is Rani Therapeutics Holdings in?

Rani Therapeutics Holdings is in the Healthcare sector

What industry is Rani Therapeutics Holdings in?

Rani Therapeutics Holdings is in the Biotechnology industry

What country is Rani Therapeutics Holdings based in?

Rani Therapeutics Holdings is headquartered in United States

When did Rani Therapeutics Holdings go public?

Rani Therapeutics Holdings's initial public offering (IPO) was on July 30, 2021

Is Rani Therapeutics Holdings in the S&P 500?

No, Rani Therapeutics Holdings is not included in the S&P 500 index

Is Rani Therapeutics Holdings in the NASDAQ 100?

No, Rani Therapeutics Holdings is not included in the NASDAQ 100 index

Is Rani Therapeutics Holdings in the Dow Jones?

No, Rani Therapeutics Holdings is not included in the Dow Jones index

When was Rani Therapeutics Holdings's last earnings report?

Rani Therapeutics Holdings's most recent earnings report was on Mar 31, 2025

When does Rani Therapeutics Holdings report earnings?

The next expected earnings date for Rani Therapeutics Holdings is May 6, 2025

Should I buy Rani Therapeutics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page